MedPath
HSA Approval

POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (400 mEq/l)

SIN11566P

POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (400 mEq/l)

POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (400 mEq/l)

June 21, 2001

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05BB01

electrolytes

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

Baxter Healthcare Corporation

Baxter Healthcare Philippines Inc.

Active Ingredients

POTASSIUM CHLORIDE

1.49 g/50 ml

Potassium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (400 mEq/l) - HSA Approval | MedPath